Hippocampal integrity and neurocognition in first-episode schizophrenia: A multidimensional study

World Journal of Biological Psychiatry

Volumn 15, Issue 3, 2014, Pages 188-199

  Hasan, Alkomiet ^a,e   Wobrock, Thomas ^a,e   Falkai, Peter ^a   Schneider Axmann, Thomas ^a   Guse, Birgit ^a   Backens, Martin ^c   Ecker, Ullrich K H ^d   Heimes, Janina ^a   Galea, Joseph Michael ^e,f   Gruber, Oliver ^a   Scherk, Harald ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b AMEOS Klinikum Osnabr Ü Ck   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f Darmstadt Dieburg Clinics   (Germany)

Author keywords

First episode schizophrenia; Hippocampus; MRI; MRS; Neurocognition

Indexed keywords

CHOLINE; CREATINE; CREATINE PHOSPHATE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID; NEUROTRANSMITTER;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN MALFORMATION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; MENTAL TEST; NEUROCHEMISTRY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARANOID SCHIZOPHRENIA; PROTON NUCLEAR MAGNETIC RESONANCE; RECALL; RECOGNITION; VERBAL MEMORY; VOLUMETRY; WORKING MEMORY;

ADULT; CASE-CONTROL STUDIES; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY DISORDERS; MIDDLE AGED; ORGAN SIZE; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84896787075     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.620002     Document Type: Article

References (58)

1. Aleman A, Hijman R, de Haan EH, Kahn RS. 1999. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 156:1358-66. (Pubitemid 29416531)
2. Antonova E, Sharma T, Morris R, Kumari V. 2004. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr Res 70:117-45. (Pubitemid 39141094)
3. Bassett AS, Collins EJ, Nuttall SE, Honer WG. 1993. Positive and negative symptoms in families with schizophrenia. Schizophr Res 11:9-19. (Pubitemid 23363161)
4. Bluml S, Seymour KJ, Ross BD. 1999. Developmental changes in choline-and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in in vivo human brain. Magn Reson Med 42:643-54. (Pubitemid 29468293)
5. DeLisi LE, Stritzke PH, Holan V, Anand A, Boccio A, Kuschner M, et al. 1991. Brain morphological changes in 1st episode cases of schizophrenia: are they progressive? Schizophr Res 5:206-8.
6. Endicott J, Spitzer RL, Fleiss JL, Cohen J. 1976. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 33:766-71.
7. Gaffan D. 2005. Neuroscience. Widespread cortical networks underlie memory and attention. Science 309:2172-3. (Pubitemid 41396057)
8. Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, et al. 2009. Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study. Schizophr Res 115:104-14.
9. Green MF. 1996. What are the functional consequences of neurocognitive defi cits in schizophrenia? Am J Psychiatry 153:321-30. (Pubitemid 26074706)
10. Gruber O, Falkai P, Schneider-Axmann T, Schwab SG, Wagner M, Maier W. 2008. Neuregulin-1 haplotype HAP(ICE) is associated with lower hippocampal volumes in schizophrenic patients and in non-affected family members. J Psychiatr Res 43:1-6.
11. Gur RE, Turetsky BI, Cowell PE, Finkelman C, Maany V, Grossman RI, et al. 2000. Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 57:769-75. (Pubitemid 30650112)
12. Guy W BR. 1976. CGI: Clinical Global Impressions. Manual for the ECDEU Assessment Battery. 2nd Rev ed. Chevy chase, MD: National Institute of Mental Health. p. 12/1-12/6.
13. Harrison PJ. 2004. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berlin) 174:151-62. (Pubitemid 38925100)
14. Heaton RK CG, Talley JL, Kay GG, Curtiss G. 1993. Wisconsin Card Sorting Test Manual-Revised and expanded. Lutz, FL: PAR.
15. Helmstaedter C, Wietzke J, Lutz MT. 2009. Unique and shared validity of the "Wechsler logical memory test", the "California verbal learning test", and the "verbal learning and memory test" in patients with epilepsy. Epilepsy Res 87:203-12.
16. Henseler I, Falkai P, Gruber O. 2009. A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia. Eur J Neurosci 30:693-702.
17. Henseler I, Falkai P, Gruber O. 2010. Disturbed functional connectivity within brain networks subserving domain-specifi c subcomponents of working memory in schizophrenia: relation to performance and clinical symptoms. J Psychiatr Res 44: 364-72.
18. Hopfi nger JB, Buonocore MH, Mangun GR. 2000. The neural mechanisms of top-down attentional control. Nat Neurosci 3:284-91. (Pubitemid 30140792)
19. Jamrozinski K, Gruber O, Kemmer C, Falkai P, Scherk H. 2009. Neurocognitive functions in euthymic bipolar patients. Acta Psychiatr Scand 119:365-74.
20. Jessen F, Block W, Traber F, Keller E, Flacke S, Papassotiropoulos A, et al. 2000. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD. Neurology 55:684-8.
21. Jessen F, Block W, Traber F, Keller E, Flacke S, Lamerichs R, et al. 2001. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 57:930-2. (Pubitemid 32845528)
22. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-76. (Pubitemid 18039085)
23. Klar AA, Ballmaier M, Leopold K, Hake I, Schaefer M, Bruhl R, et al. 2010. Interaction of hippocampal volume and Nacetylaspartate concentration defi cits in schizophrenia: a combined MRI and 1H-MRS study. Neuroimage 53:51-7.
24. Konradi C, Heckers S. 2003. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97:153-79. (Pubitemid 36138820)
25. Kubicki M, McCarley RW, Nestor PG, Huh T, Kikinis R, Shenton ME, et al. 2003. An fMRI study of semantic processing in men with schizophrenia. Neuroimage 20:1923-33. (Pubitemid 37543611)
26. Laws KR. 1999. A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: general intellectual defi cit in disguise? Cogn Neuropsychiatry 4:1-30; discussion 31-5.
27. Maier M, Ron MA, Barker GJ, Tofts PS. 1995. Proton magnetic resonance spectroscopy: an in vivo method of estimating hippocampal neuronal depletion in schizophrenia. Psychol Med 25:1201-9.
28. Maudsley AA, Domenig C, Govind V, Darkazanli A, Studholme C, Arheart K, et al. 2009. Mapping of brain metabolite distributions by volumetric proton MR spectroscopic imaging (MRSI). Magn Reson Med 61:548-59.
29. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. 2009. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23:315-36.
30. Muller H, Hasse-Sander I, Horn R, Helmstaedter C, Elger CE. 1997. Rey Auditory-Verbal Learning Test: structure of a modifi ed German version. J Clin Psychol 53:663-71. (Pubitemid 27454569)
31. Panenka WJ, Khorram B, Barr AM, Smith GN, Lang DJ, Kopala LC, et al. 2007. A longitudinal study on the effects of typical versus atypical antipsychotic drugs on hippocampal volume in schizophrenia. Schizophr Res 94:288-92. (Pubitemid 47031604)
32. Paz RD, Tardito S, Atzori M, Tseng KY. 2008. Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology. Eur Neuropsychopharmacol 18: 773-86.
33. Petrides M, Milner B. 1982. Defi cits on subject-ordered tasks after frontal-and temporal-lobe lesions in man. Neuropsychologia 20:249-62. (Pubitemid 12090805)
34. Ragland JD, Gur RC, Valdez J, Turetsky BI, Elliott M, Kohler C, et al. 2004. Event-related fMRI of frontotemporal activity during word encoding and recognition in schizophrenia. Am J Psychiatry 161:1004-15. (Pubitemid 38735986)
35. Raz N, Rodrigue KM, Head D, Kennedy KM, Acker JD. 2004. Differential aging of the medial temporal lobe: a study of a fi ve-year change. Neurology 62:433-8. (Pubitemid 38200856)
36. Remillard S, Pourcher E, Cohen H. 2005. The effect of neuroleptic treatments on executive function and symptomatology in schizophrenia: a 1-year follow up study. Schizophr Res 80: 99-106. (Pubitemid 41587467)
37. Rose SE, de Zubicaray GI, Wang D, Galloway GJ, Chalk JB, Eagle SC, et al. 1999. A 1H MRS study of probable Alzheimer's disease and normal aging: implications for longitudinal monitoring of dementia progression. Magn Reson Imaging 17:291-9. (Pubitemid 29053189)
38. Scherk H, Backens M, Zill P, Schneider-Axmann T, Wobrock T, Usher J, et al. 2008. SNAP-25 genotype infl uences NAA/Cho in left hippocampus. J Neural Transm 115:1513-8.
39. Schmidt KH, Metzler P. 1992. Wortschatztest WST. Weinheim: Beltz.
40. Seidman LJ, Faraone SV, Goldstein JM, Kremen WS, Horton NJ, Makris N, et al. 2002. Left hippocampal volume as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric study of nonpsychotic first-degree relatives. Arch Gen Psychiatry 59:839-49. (Pubitemid 35001150)
41. Steen RG, Hamer RM, Lieberman JA. 2005. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and metaanalysis. Neuropsychopharmacology 30:1949-62. (Pubitemid 43093497)
42. Steen RG, Mull C, McClure R, Hamer RM, Lieberman JA. 2006. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. Br J Psychiatry 188:510-8. (Pubitemid 43844097)
43. Stern AJ, Savostyanova AA, Goldman A, Barnett AS, van der Veen JW, Callicott JH, et al. 2008. Impact of the brainderived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl-aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biol Psychiatry 64:856-62.
44. Szeszko PR, Goldberg E, Gunduz-Bruce H, Ashtari M, Robinson D, Malhotra AK, et al. 2003. Smaller anterior hippocampal formation volume in antipsychotic-naive patients with firstepisode schizophrenia. Am J Psychiatry 160:2190-7. (Pubitemid 39619612)
45. Talairach J, Tournoux P. 1998. Coplanar sterotaxic atlas of the human brain. New York: Thieme Medical Publishers.
46. Tamminga CA, Stan AD, Wagner AD. 2010. The hippocampal formation in schizophrenia. Am J Psychiatry 167(10): 1178-93.
47. Thoma RJ, Monnig M, Hanlon FM, Miller GA, Petropoulos H, Mayer AR, et al. 2009. Hippocampus volume and episodic memory in schizophrenia. J Int Neuropsychol Soc 15:182-95.
48. Torres IJ, Flashman LA, O'Leary DS, Swayze V 2nd, Andreasen NC. 1997. Lack of an association between delayed memory and hippocampal and temporal lobe size in patients with schizophrenia and healthy controls. Biol Psychiatry 42: 1087-96. (Pubitemid 28049920)
49. Valenzuela MJ, Sachdev P. 2001. Magnetic resonance spectroscopy in AD. Neurology 56:592-8. (Pubitemid 32209990)
50. Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, et al. 2006. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry 63:139-49. (Pubitemid 43213875)
51. Watanabe T, Shiino A, Akiguchi I. 2010. Absolute quantifi cation in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 30:71-7.
52. Weiss AP, Zalesak M, DeWitt I, Goff D, Kunkel L, Heckers S. 2004. Impaired hippocampal function during the detection of novel words in schizophrenia. Biol Psychiatry 55: 668-75. (Pubitemid 38376177)
53. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. 1997.
54. Strukturiertes Klinisches Interview f ür DSM-IV. Achse I: Psychische St örungen. A German, advanced adaptation of the original SCID version by Spitzer RL, Williams JB, Gibbon M, First MB. G öttingen: Hogrefe-Verlag.
55. Wobrock T, Ecker UK, Scherk H, Schneider-Axmann T, Falkai P, Gruber O. 2009. Cognitive impairment of executive function as a core symptom of schizophrenia. World J Biol Psychiatry 10:442-51.
56. Yildiz-Yesiloglu A, Ankerst DP. 2006. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy fi ndings. Prog Neuropsychopharmacol Biol Psychiatry 30:969-95. (Pubitemid 43928209)
57. Zierhut K, Bogerts B, Schott B, Fenker D, Walter M, Albrecht D, et al. 2010. The role of hippocampus dysfunction in defi-cient memory encoding and positive symptoms in schizophrenia. Psychiatry Res 183:187-94.
58. Zilles D, Burke S, Schneider-Axmann T, Falkai P, Gruber O. 2009. Diagnosis-specifi c effect of familial loading on verbal working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:309-15.